FDA announces labeling changes to opioid pain medications
The Food and Drug Administration July 31 announced that it is requiring safety label changes to all opioid pain medications to further emphasize and explain the risks associated with long-term use. The updates include presenting clearer risk information, stronger dosing warnings, clarified language on use limits, treatment guidance and more. Manufacturers were given 30 days to submit their labeling updates to the FDA for review.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
